Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 2Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 14Leukemia, Myeloid, Acute 7Neoplasms 3Neoplasm Metastasis 3Thyroid Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Neuroblastoma 2Liver Neoplasms 2Hepatoblastoma 2Fibrolamellar hepatocellular carcinoma 2Tongue Neoplasms 1Thyroid cancer, Hurthle cell 1Thyroid Diseases 1Sarcoma, Myeloid 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Recurrence 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasm, Residual 1Myelodysplastic Syndromes 1Metastatic Colorectal Cancer Patients With KRAS Mutated Tumors 1Melanoma 1Gastrointestinal Stromal Tumors 1Desmoplastic Small Round Cell Tumor 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Renal Cell 1

Interventions

pembrolizumab 105Specimen Handling 55Magnetic Resonance Spectroscopy 48Biopsy 47Nivolumab 40Paclitaxel 35Gemcitabine 30Radiosurgery 29Carboplatin 28Irinotecan 22Ipilimumab 22Cyclophosphamide 22Cisplatin 22trastuzumab deruxtecan 21Leucovorin 19Capecitabine 19Fluorouracil 18Cetuximab 18Bevacizumab 18130-nm albumin-bound paclitaxel 18Pemetrexed 17Fulvestrant 17Drug Therapy 16Docetaxel 16Taxes 15Oxaliplatin 15olaparib 14abemaciclib 14Radiotherapy 14palbociclib 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Sorafenib × 1 year × Clear all
NCT01187199 2026-04-16

Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer

M.D. Anderson Cancer Center

Phase 1 Active not recruiting
278 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT05068752 2026-03-30

Phase II Trial of Vemurafenib and Sorafenib in Pancreatic Cancer

HonorHealth Research Institute

Phase 2 Completed
10 enrolled 15 charts
Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms

NCT02029001 2025-08-07

MOST plus

Centre Leon Berard

Phase 2 Recruiting
900 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡